Both gluten-specific CD4+ T cells9,10 and TG3-specific gut plasma cells11,12 have been demonstrated in DH patients, suggesting that the anti-TG3 response could be induced in the gut through similar mechanisms as described for the anti-TG2 response in CeD. This evidence concerns the gene CD4 and cranioectodermal dysplasia.